Acetazolamide
 Acetazolamide Tablets

drug-information.ru

|Acetazolamide Acetazolamide Tablets

Drugs search, click the first letter of a drug name:


| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 2 | 3 | 4 | 5 | 6 | 8 | 9  Home

Acetazolamide

Dosage Form: Injection, usp

For Intravenous Use.

Rx ONLY.

Acetazolamide Description

Acetazolamide, an inhibitor of the enzyme carbonic anhydrase, is a white to faintly yellowish white crystalline, odorless powder, weakly acidic, very slightly soluble in water and slightly soluble in alcohol. The chemical name for Acetazolamide is N-(5-Sulfamoyl-1,3,4-thiadiazol-2yl)-acetamide and has the following structural formula:

M.W. 222.24                                                                                                          C4H6N4O3S2

Acetazolamide is available for intravenous use, and is supplied as a sterile powder requiring reconstitution. Each vial contains Acetazolamide sodium equivalent to 500 mg of Acetazolamide. The bulk solution is adjusted to pH 9.6 using sodium hydroxide and, if necessary, hydrochloric acid prior to lyophilization.

Acetazolamide - Clinical Pharmacology

Acetazolamide is a potent carbonic anhydrase inhibitor, effective in the control of fluid secretion (e.g., some types of glaucoma), in the treatment of certain convulsive disorders (e.g., epilepsy) and in the promotion of diuresis in instances of abnormal fluid retention (e.g., cardiac edema).

Acetazolamide is not a mercurial diuretic. Rather, it is a nonbacteriostatic sulfonamide possessing a chemical structure and pharmacological activity distinctly different from the bacteriostatic sulfonamides.

Acetazolamide is an enzyme inhibitor that acts specifically on carbonic anhydrase, the enzyme that catalyzes the reversible reaction involving the hydration of carbon dioxide and the dehydration of carbonic acid. In the eye, this inhibitory action of Acetazolamide decreases the secretion of aqueous humor and results in a drop in intraocular pressure, a reaction considered desirable in cases of glaucoma and even in certain nonglaucomatous conditions. Evidence seems to indicate that Acetazolamide has utility as an adjuvant in the treatment of certain dysfunctions of the central nervous system (e.g., epilepsy).

Inhibition of carbonic anhydrase in this area appears to retard abnormal, paroxysmal, excessive discharge from central nervous system neurons. The diuretic effect of Acetazolamide is due to its action in the kidney on the reversible reaction involving hydration of carbon dioxide and dehydration of carbonic acid.

The result is renal loss of HCO3 ion, which carries out sodium, water, and potassium. Alkalinization of the urine and promotion of diuresis are thus effected. Alteration in ammonia metabolism occurs due to increased reabsorption of ammonia by the renal tubules as a result of urinary alkalinization.

Indications and Usage for Acetazolamide

For adjunctive treatment of: edema due to congestive heart failure; drug-induced edema; centrencephalic epilepsies (petit mal, unlocalized seizures); chronic simple (open-angle) glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where delay of surgery is desired in order to lower intraocular pressure.

Contraindications

Acetazolamide therapy is contraindicated in situations in which sodium and/or potassium blood serum levels are depressed, in cases of marked kidney and liver disease or dysfunction, in suprarenal gland failure, and in hyperchloremic acidosis. It is contraindicated in patients with cirrhosis because of the risk of development of hepatic encephalopathy.

Long-term administration of Acetazolamide is contraindicated in patients with chronic noncongestive angle-closure glaucoma since it may permit organic closure of the angle to occur while the worsening glaucoma is masked by lowered intraocular pressure.

Warnings

Fatalities have occurred, although rarely, due to severe reactions to sulfonamides including Stevens-Johnson syndrome, toxic epidermal necrolysis, fulminant hepatic necrosis, agranulocytosis, aplastic anemia, and other blood dyscrasias. Sensitizations may recur when a sulfonamide is readministered irrespective of the route of administration. If signs of hypersensitivity or other serious reactions occur, discontinue use of this drug.

Caution is advised for patients receiving concomitant high-dose aspirin and Acetazolamide, as anorexia, tachypnea, lethargy, coma and death have been reported.

Precautions

General

Increasing the dose does not increase the diuresis and may increase the incidence of drowsiness and/or paresthesia. Increasing the dose often results in a decrease in diuresis. Under certain circumstances, however, very large doses have been given in conjunction with other diuretics in order to secure diuresis in complete refractory failure.

Information for Patients

Adverse reactions common to all sulfonamide derivatives may occur: anaphylaxis, fever, rash (including erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis), crystalluria, renal calculus, bone marrow depression, thrombocytopenic purpura, hemolytic anemia, leukopenia, pancytopenia and agranulocytosis. Precaution is advised for early detection of such reactions and the drug should be discontinued and appropriate therapy instituted.

In patients with pulmonary obstruction or emphysema where alveolar ventilation may be impaired, Acetazolamide which may precipitate or aggravate acidosis, should be used with caution.

Caution is advised for patients receiving concomitant high-dose aspirin and Acetazolamide, as anorexia, tachypnea, lethargy, coma and death have been reported (see WARNINGS).

Laboratory Tests

To monitor for hematologic reactions common to all sulfonamides, it is recommended that a baseline CBC and platelet count be obtained on patients prior to initiating Acetazolamide therapy and at regular intervals during therapy. If significant changes occur, early discontinuance and institution of appropriate therapy are important. Periodic monitoring of serum electrolytes is recommended.

Carcinogenesis, Mutagenesis, Impairment of Fertility

Long-term studies in animals to evaluate the carcinogenic potential of Acetazolamide have not been conducted. In a bacterial mutagenicity assay, Acetazolamide was not mutagenic when evaluated with and without metabolic activation. The drug had no effect on fertility when administered in the diet to male and female rats at a daily intake of up to 4 times the recommended human dose of 1000 mg in a 50 kg individual.

Pregnancy

Teratogenic effects: Pregnancy Category C

Acetazolamide, administered orally or parenterally, has been shown to be teratogenic (defects of the limbs) in mice, rats, hamsters and rabbits. There are no adequate and well-controlled studies in pregnant women. Acetazolamide should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus.

Nursing Mothers

Because of the potential for serious adverse reaction in nursing infants from Acetazolamide, a decision should be made whether to discontinue nursing or to discontinue the drug taking into account the importance of the drug to the mother.

Pediatric Use

The safety and effectiveness of Acetazolamide in children have not been established.

Adverse Reactions

Adverse reactions, occurring most often early in therapy, include paresthesias, particularly a “tingling” feeling in the extremities, hearing dysfunction or tinnitus, loss of appetite, taste alteration and gastrointestinal disturbances such as nausea, vomiting and diarrhea; polyuria, and occasional instances of drowsiness and confusion.

Metabolic acidosis and electrolyte imbalance may occur.

Transient myopia has been reported. This condition invariably subsides upon diminution or discontinuance of the medication.

Other occasional adverse reactions include urticaria, melena, hematuria, glycosuria, hepatic insufficiency, flaccid paralysis, photosensitivity and convulsions. Also see PRECAUTIONS: Information for Patients for possible reactions common to sulfonamide derivatives. Fatalities have occurred although rarely, due to severe reactions to sulfonamides including Stevens-Johnson syndrome, toxic epidermal necrolysis, fulminant hepatic necrosis, agranulocytosis, aplastic anemia and other blood dyscrasias (see WARNINGS).

Overdosage

No data are available regarding Acetazolamide overdosage in humans as no cases of acute poisoning with this drug have been reported. Animal data suggest that Acetazolamide is remarkably nontoxic. No specific antidote is known. Treatment should be symptomatic and supportive.

Electrolyte imbalance, development of an acidotic state, and central nervous effects might be expected to occur. Serum electrolyte levels (particularly potassium) and blood pH levels should be monitored.

Supportive measures are required to restore electrolyte and pH balance. The acidotic state can usually be corrected by the administration of bicarbonate.

Despite its high intraerythrocytic distribution and plasma protein binding properties, Acetazolamide may be dialyzable. This may be particularly important in the management of Acetazolamide overdosage when complicated by the presence of renal failure.

Acetazolamide Dosage and Administration

Preparation and Storage of Parenteral Solution

Each 500 mg vial containing sterile Acetazolamide sodium should be reconstituted with at least 5 mL of Sterile Water for Injection prior to use. Reconstituted solutions retain their physical and chemical properties for 3 days under refrigeration at 2° - 8° C (36° - 46° F), or 12 hours at

room temperature 15° - 30° C (59° - 86° F). Contains no preservative. The direct intravenous route of administration is preferred. Intramuscular administration is not recommended.

Glaucoma

Acetazolamide should be used as an adjunct to the usual therapy. The dosage employed in the treatment of chronic simple (open-angle) glaucoma ranges from 250 mg to 1 g of Acetazolamide per 24 hours, usually in divided doses for amounts over 250 mg. It has usually been found that a dosage in excess of 1 g per 24 hours does not produce an increased effect. In all cases, the dosage should be adjusted with careful individual attention both to symptomatology and ocular tension. Continuous supervision by a physician is advisable.

In treatment of secondary glaucoma and in the preoperative treatment of some cases of acute congestive (closed-angle) glaucoma, the preferred dosage is 250 mg every four hours, although some cases have responded to 250 mg twice daily on short-term therapy. In some acute cases, it may be more satisfactory to administer an initial dose of 500 mg followed by 125 or 250 mg every four hours depending on the individual case. Intravenous therapy may be used for rapid relief of ocular tension in acute cases. A complementary effect has been noted when Acetazolamide has been used in conjunction with miotics or mydriatics as the case demanded.

Epilepsy

It is not clearly known whether the beneficial effects observed in epilepsy are due to direct inhibition of carbonic anhydrase in the central nervous system or whether they are due to the slight degree of acidosis produced by the divided dosage. The best results to date have been seen in petit mal in children. Good results, however, have been seen in patients, both children and adult, in other types of seizures such as grand mal, mixed seizure patterns, myoclonic jerk patterns, etc. The suggested total daily dose is 8 to 30 mg per kg in divided doses. Although some patients respond to a low dose, the optimum range appears to be from 375 to 1000 mg daily. However, some investigators feel that daily doses in excess of 1 g do not produce any better results than a 1 g dose. When Acetazolamide is given in combination with other anticonvulsants, it is suggested that the starting dose should be 250 mg once daily in addition to the existing medications. This can be increased to levels as indicated above.

The change from other medications to Acetazolamide should be gradual and in accordance with usual practice in epilepsy therapy.

Congestive Heart Failure

For diuresis in congestive heart failure, the starting dose is usually 250 to 375 mg once daily in the morning (5 mg per kg). If, after an initial response, the patient fails to continue to lose edema fluid, do not increase the dose but allow for kidney recovery by skipping medication for a day.

Acetazolamide yields best diuretic results when given on alternate days, or for two days alternating with a day of rest.

Failures in therapy may be due to overdosage or too frequent dosage. The use of Acetazolamide does not eliminate the need for other therapy such as digitalis, bed rest, and salt restriction.

Drug-Induced Edema

Recommended dosage is 250 to 375 mg of Acetazolamide once a day for one or two days, alternating with a day of rest.

Note: The dosage recommendations for glaucoma and epilepsy differ considerably from those for congestive heart failure, since the first two conditions are not dependent upon carbonic anhydrase inhibition in the kidney which requires intermittent dosage if it is to recover from inhibitory effect of the therapeutic agent.

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.

How is Acetazolamide Supplied

Intravenous

Acetazolamide for Injection USP (lyophilized) powder.

NDC 55390-460-01 500 mg Vial

Store drug product at controlled room temperature

15°-30°C (59°-86°F).

Reconstituted solution should be stored in refrigerator at 2°- 8°C (36° - 46°F).

Use within 12 hours of reconstitution. Contains no preservative. Discard unused portion.

Manufactured by:                                                    Manufactured for:

Ben Venue Laboratories, Inc.                                    Bedford Laboratories™

270 Northfield Road                                                 270 Northfield Road

Bedford, Ohio 44146                                                Bedford, Ohio 44146

October 2002                                                           ACP02


Acetazolamide (Acetazolamide)
PRODUCT INFO
Product Code 55390-460 Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Of Administration INTRAVENOUS DEA Schedule
INGREDIENTS
Name (Active Moiety) Type Strength
Acetazolamide (Acetazolamide) Active 500 MILLIGRAM  In 1 VIAL
hydrochloric acid Inactive  
sodium hydroxide Inactive  
IMPRINT INFORMATION
Characteristic Appearance Characteristic Appearance
Color Score
Shape Symbol
Imprint Code Coating
Size
PACKAGING
# NDC Package Description Multilevel Packaging
1 55390-460-01 1 VIAL In 1 BOX, UNIT-DOSE contains a VIAL
1 1 VIAL In 1 VIAL This package is contained within the BOX, UNIT-DOSE (55390-460-01)

Revised: 10/2006





Where can I get more information about Acetazolamide Acetazolamide Tablets ? We recommend to use www.Drugs.com

Typical mistypes for Acetazolamide Acetazolamide Tablets
zcetazolamide acetazolamide tablets, scetazolamide acetazolamide tablets, wcetazolamide acetazolamide tablets, qcetazolamide acetazolamide tablets, axetazolamide acetazolamide tablets, avetazolamide acetazolamide tablets, afetazolamide acetazolamide tablets, adetazolamide acetazolamide tablets, acwtazolamide acetazolamide tablets, acstazolamide acetazolamide tablets, acdtazolamide acetazolamide tablets, acrtazolamide acetazolamide tablets, ac4tazolamide acetazolamide tablets, ac3tazolamide acetazolamide tablets, acerazolamide acetazolamide tablets, acefazolamide acetazolamide tablets, acegazolamide acetazolamide tablets, aceyazolamide acetazolamide tablets, ace6azolamide acetazolamide tablets, ace5azolamide acetazolamide tablets, acetzzolamide acetazolamide tablets, acetszolamide acetazolamide tablets, acetwzolamide acetazolamide tablets, acetqzolamide acetazolamide tablets, acetaxolamide acetazolamide tablets, acetasolamide acetazolamide tablets, acetaaolamide acetazolamide tablets, acetazilamide acetazolamide tablets, acetazklamide acetazolamide tablets, acetazllamide acetazolamide tablets, acetazplamide acetazolamide tablets, acetaz0lamide acetazolamide tablets, acetaz9lamide acetazolamide tablets, acetazokamide acetazolamide tablets, acetazopamide acetazolamide tablets, acetazooamide acetazolamide tablets, acetazolzmide acetazolamide tablets, acetazolsmide acetazolamide tablets, acetazolwmide acetazolamide tablets, acetazolqmide acetazolamide tablets, acetazolanide acetazolamide tablets, acetazolakide acetazolamide tablets, acetazolajide acetazolamide tablets, acetazolamude acetazolamide tablets, acetazolamjde acetazolamide tablets, acetazolamkde acetazolamide tablets, acetazolamode acetazolamide tablets, acetazolam9de acetazolamide tablets, acetazolam8de acetazolamide tablets, acetazolamise acetazolamide tablets, acetazolamixe acetazolamide tablets, acetazolamice acetazolamide tablets, acetazolamife acetazolamide tablets, acetazolamire acetazolamide tablets, acetazolamiee acetazolamide tablets, acetazolamidw acetazolamide tablets, acetazolamids acetazolamide tablets, acetazolamidd acetazolamide tablets, acetazolamidr acetazolamide tablets, acetazolamid4 acetazolamide tablets, acetazolamid3 acetazolamide tablets, acetazolamide zcetazolamide tablets, acetazolamide scetazolamide tablets, acetazolamide wcetazolamide tablets, acetazolamide qcetazolamide tablets, acetazolamide axetazolamide tablets, acetazolamide avetazolamide tablets, acetazolamide afetazolamide tablets, acetazolamide adetazolamide tablets, acetazolamide acwtazolamide tablets, acetazolamide acstazolamide tablets, acetazolamide acdtazolamide tablets, acetazolamide acrtazolamide tablets, acetazolamide ac4tazolamide tablets, acetazolamide ac3tazolamide tablets, acetazolamide acerazolamide tablets, acetazolamide acefazolamide tablets, acetazolamide acegazolamide tablets, acetazolamide aceyazolamide tablets, acetazolamide ace6azolamide tablets, acetazolamide ace5azolamide tablets, acetazolamide acetzzolamide tablets, acetazolamide acetszolamide tablets, acetazolamide acetwzolamide tablets, acetazolamide acetqzolamide tablets, acetazolamide acetaxolamide tablets, acetazolamide acetasolamide tablets, acetazolamide acetaaolamide tablets, acetazolamide acetazilamide tablets, acetazolamide acetazklamide tablets, acetazolamide acetazllamide tablets, acetazolamide acetazplamide tablets, acetazolamide acetaz0lamide tablets, acetazolamide acetaz9lamide tablets, acetazolamide acetazokamide tablets, acetazolamide acetazopamide tablets, acetazolamide acetazooamide tablets, acetazolamide acetazolzmide tablets, acetazolamide acetazolsmide tablets, acetazolamide acetazolwmide tablets, acetazolamide acetazolqmide tablets, acetazolamide acetazolanide tablets, acetazolamide acetazolakide tablets, acetazolamide acetazolajide tablets, acetazolamide acetazolamude tablets, acetazolamide acetazolamjde tablets, acetazolamide acetazolamkde tablets, acetazolamide acetazolamode tablets, acetazolamide acetazolam9de tablets, acetazolamide acetazolam8de tablets, acetazolamide acetazolamise tablets, acetazolamide acetazolamixe tablets, acetazolamide acetazolamice tablets, acetazolamide acetazolamife tablets, acetazolamide acetazolamire tablets, acetazolamide acetazolamiee tablets, acetazolamide acetazolamidw tablets, acetazolamide acetazolamids tablets, acetazolamide acetazolamidd tablets, acetazolamide acetazolamidr tablets, acetazolamide acetazolamid4 tablets, acetazolamide acetazolamid3 tablets, acetazolamide acetazolamide rablets, acetazolamide acetazolamide fablets, acetazolamide acetazolamide gablets, acetazolamide acetazolamide yablets, acetazolamide acetazolamide 6ablets, acetazolamide acetazolamide 5ablets, acetazolamide acetazolamide tzblets, acetazolamide acetazolamide tsblets, acetazolamide acetazolamide twblets, acetazolamide acetazolamide tqblets, acetazolamide acetazolamide tavlets, acetazolamide acetazolamide tanlets, acetazolamide acetazolamide tahlets, acetazolamide acetazolamide taglets, acetazolamide acetazolamide tabkets, acetazolamide acetazolamide tabpets, acetazolamide acetazolamide taboets, acetazolamide acetazolamide tablwts, acetazolamide acetazolamide tablsts, acetazolamide acetazolamide tabldts, acetazolamide acetazolamide tablrts, acetazolamide acetazolamide tabl4ts, acetazolamide acetazolamide tabl3ts, acetazolamide acetazolamide tablers, acetazolamide acetazolamide tablefs, acetazolamide acetazolamide tablegs, acetazolamide acetazolamide tableys, acetazolamide acetazolamide table6s, acetazolamide acetazolamide table5s, acetazolamide acetazolamide tableta, acetazolamide acetazolamide tabletz, acetazolamide acetazolamide tabletx, acetazolamide acetazolamide tabletd, acetazolamide acetazolamide tablete, acetazolamide acetazolamide tabletw, cetazolamide acetazolamide tablets, aetazolamide acetazolamide tablets, actazolamide acetazolamide tablets, aceazolamide acetazolamide tablets, acetzolamide acetazolamide tablets, acetaolamide acetazolamide tablets, acetazlamide acetazolamide tablets, acetazoamide acetazolamide tablets, acetazolmide acetazolamide tablets, acetazolaide acetazolamide tablets, acetazolamde acetazolamide tablets, acetazolamie acetazolamide tablets, acetazolamid acetazolamide tablets, acetazolamide acetazolamide tablets, acetazolamide acetazolamide tablets, acetazolamide cetazolamide tablets, acetazolamide aetazolamide tablets, acetazolamide actazolamide tablets, acetazolamide aceazolamide tablets, acetazolamide acetzolamide tablets, acetazolamide acetaolamide tablets, acetazolamide acetazlamide tablets, acetazolamide acetazoamide tablets, acetazolamide acetazolmide tablets, acetazolamide acetazolaide tablets, acetazolamide acetazolamde tablets, acetazolamide acetazolamie tablets, acetazolamide acetazolamid tablets, acetazolamide acetazolamidetablets, acetazolamide acetazolamide ablets, acetazolamide acetazolamide tblets, acetazolamide acetazolamide talets, acetazolamide acetazolamide tabets, acetazolamide acetazolamide tablts, acetazolamide acetazolamide tables, acetazolamide acetazolamide tablet, caetazolamide acetazolamide tablets, aectazolamide acetazolamide tablets, acteazolamide acetazolamide tablets, aceatzolamide acetazolamide tablets, acetzaolamide acetazolamide tablets, acetaozlamide acetazolamide tablets, acetazloamide acetazolamide tablets, acetazoalmide acetazolamide tablets, acetazolmaide acetazolamide tablets, acetazolaimde acetazolamide tablets, acetazolamdie acetazolamide tablets, acetazolamied acetazolamide tablets, acetazolamid e acetazolamide tablets, acetazolamide acetazolamide tablets, acetazolamide a cetazolamide tablets, acetazolamide caetazolamide tablets, acetazolamide aectazolamide tablets, acetazolamide acteazolamide tablets, acetazolamide aceatzolamide tablets, acetazolamide acetzaolamide tablets, acetazolamide acetaozlamide tablets, acetazolamide acetazloamide tablets, acetazolamide acetazoalmide tablets, acetazolamide acetazolmaide tablets, acetazolamide acetazolaimde tablets, acetazolamide acetazolamdie tablets, acetazolamide acetazolamied tablets, acetazolamide acetazolamid etablets, acetazolamide acetazolamidet ablets, acetazolamide acetazolamide atblets, acetazolamide acetazolamide tbalets, acetazolamide acetazolamide talbets, acetazolamide acetazolamide tabelts, acetazolamide acetazolamide tabltes, acetazolamide acetazolamide tablest, aacetazolamide acetazolamide tablets, accetazolamide acetazolamide tablets, aceetazolamide acetazolamide tablets, acettazolamide acetazolamide tablets, acetaazolamide acetazolamide tablets, acetazzolamide acetazolamide tablets, acetazoolamide acetazolamide tablets, acetazollamide acetazolamide tablets, acetazolaamide acetazolamide tablets, acetazolammide acetazolamide tablets, acetazolamiide acetazolamide tablets, acetazolamidde acetazolamide tablets, acetazolamidee acetazolamide tablets, acetazolamide acetazolamide tablets, acetazolamide acetazolamide tablets, acetazolamide aacetazolamide tablets, acetazolamide accetazolamide tablets, acetazolamide aceetazolamide tablets, acetazolamide acettazolamide tablets, acetazolamide acetaazolamide tablets, acetazolamide acetazzolamide tablets, acetazolamide acetazoolamide tablets, acetazolamide acetazollamide tablets, acetazolamide acetazolaamide tablets, acetazolamide acetazolammide tablets, acetazolamide acetazolamiide tablets, acetazolamide acetazolamidde tablets, acetazolamide acetazolamidee tablets, acetazolamide acetazolamide tablets, acetazolamide acetazolamide ttablets, acetazolamide acetazolamide taablets, acetazolamide acetazolamide tabblets, acetazolamide acetazolamide tabllets, acetazolamide acetazolamide tableets, acetazolamide acetazolamide tabletts, acetazolamide acetazolamide tabletss, etc.



© Copyright by drug-information.ru 2001-2019. All rights reserved